Cargo Therapeutics

Founded 2019 · CIK 0001966494 · Biotech · Acquired

CAR-T cell immunotherapy engineered with 4-1BB costimulation domain for B cell lymphoma treatment

cargotx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$69M
1 Form D · Mar 2023
43 months since last filing
Contracts
—
No federal contracts on record
Patents
27
0 granted · 27 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$68,832,003
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1949GENECENTRIX INC.——
1950SCALED MICROBIOMICS, LLC——
1951RYLTI, LLC—$2.3M
1952Cargo Therapeutics—$69M
1953Plex Pharmaceuticals, Inc.——
1954Caring Brands, Inc.—$1.8M
1955KIBIO INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 9 related persons
  • Abraham BassanDirector
  • Gina ChapmanDirector · Executive Officer
  • Cassandra Gianna LucaDirector
  • Heath LukatchDirector
  • Crystal MackallDirector
  • John OrwinDirector
  • Anup RadhakrishnanExecutive Officer
  • Krishnan ViswanadhanDirector
  • Jeffrey WalshDirector

Patents

USPTO · 0 granted of 27
  • Methods For Manufacturing Car T Cellsapplication
  • Compositions And Methods For Allogeneic Immune Cellsapplication
  • Compositions And Methods For Allogeneic Immune Cellsapplication
  • Methods For Manufacturing Car T Cellsapplication
  • Modified Immune Effector Cellsapplication
  • Methods For Manufacturing Car T Cellsapplication
  • Compositions And Methods For Immunotherapiesapplication
  • ANTI-CD22 Chimeric Antigen Receptor (car) Therapiesapplication
  • Compositions And Methods For Allogeneic Immune Cellsapplication
  • Compositions And Methods For Immunotherapiesapplication
  • Multiplex Cell Selection Compositions And Uses Thereofapplication
  • Compositions And Methods For Immunotherapiesapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.